Biocon Biocon views GLP-1 as a significant opportunity, citing its robust portfolio of GLP-1s and insulin products
So there is a possibility the favourable findings for this group of drugs may relate to the people who take them having some additional socioeconomic advantages, including diet, greater or more frequent access to exercise, and maybe higher or longer levels of education, that have also offered some other forms of protection. Martin Whyte, an associate professor at the University of Surrey also added, Notably, the authors did not provide detailed information about the characteristics of patients in each group, either before or after statistical matching, and treatment duration for either GLP-1 drugs or metformin was not reported
Not glamorous enough for TikTok, but it works for some people
Vasoactive Intestinal Peptide (VIP), another gut-derived peptide, acts as a potent vasodilator and has positive inotropic effects on the heart